Experts' corner

Leading international Hypoglossal Nerve Stimulation experts share their perspective on OSA, the promising future of HGNS and the Genio® system.

Responsive

Prof. Dr. Olivier Vanderveken, MD, PhD

Head of Dept. of Otorhinolaryngology Head and Neck surgery, Antwerp University Hospital (UZA), Belgium

Prof. Dr. med. Clemens Heiser

Head of the Sleep Laboratory at Klinikum rechts der Isar, Technical University of Munich
Responsive

Questions?
Visit the FAQ

Frequently asked questions
about the Genio® system

FAQ

All rights reserved © 2020 Nyxoah S.A. All content on this presentation, including the texts, trademarks, service marks, logos, illustrations, photos, graphics, design etc., are the property of Nyxoah SA. Nyxoah S.A. owns all rights with respect to any of their trademarks, service marks, logos, and copyrighted works appearing on this presentation. Patented and design protected technology. Device not for sale in U.S. The Genio® system by Nyxoah is intended to be used for patients who suffer from moderate to severe Obstructive Sleep Apnea (AHI of 15 to 65), have not tolerated, failed or refused PAP therapy and are not significantly overweight. Reviewed and approved: February 2020

bubble
bubble
bubble
bubble
bubble